| Evolution and emergence of pathogenic viruses: past, present, and future MK Parvez, S Parveen Intervirology 60 (1-2), 1-7, 2017 | 152 | 2017 |
| Herb-drug interactions and hepatotoxicity MK Parvez, V Rishi Current drug metabolism 20 (4), 275-282, 2019 | 125 | 2019 |
| ‘Ajwa’dates (Phoenix dactylifera L.) extract ameliorates isoproterenol-induced cardiomyopathy through downregulation of oxidative, inflammatory and apoptotic molecules in … M Al-Yahya, M Raish, MS AlSaid, A Ahmad, RA Mothana, M Al-Sohaibani, ... Phytomedicine 23 (11), 1240-1248, 2016 | 121 | 2016 |
| Attenuation of CCl4‐Induced Oxidative Stress and Hepatonephrotoxicity by Saudi Sidr Honey in Rats M Al-Yahya, R Mothana, M Al-Said, M Al-Dosari, N Al-Musayeib, ... Evidence‐Based Complementary and Alternative Medicine 2013 (1), 569037, 2013 | 110 | 2013 |
| Plant-derived antiviral drugs as novel hepatitis B virus inhibitors: Cell culture and molecular docking study MK Parvez, MT Rehman, P Alam, MS Al-Dosari, SI Alqasoumi, MF Alajmi Saudi Pharmaceutical Journal 27 (3), 389-400, 2019 | 108 | 2019 |
| Molecular characterization of hepatitis E virus ORF1 gene supports a papain-like cysteine protease (PCP)-domain activity MK Parvez Virus research 178 (2), 553-556, 2013 | 74 | 2013 |
| Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus SM Wakil, SN Kazim, LA Khan, S Raisuddin, MK Parvez, RC Guptan, ... Journal of medical virology 68 (3), 311-318, 2002 | 72 | 2002 |
| In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus AH Arbab, MK Parvez, MS Al‑Dosari, AJ Al‑Rehaily Experimental and therapeutic medicine 14 (1), 626-634, 2017 | 69 | 2017 |
| Bioassay-guided isolation of anti-hepatitis B virus flavonoid myricetin-3-O-rhamnoside along with quercetin from Guiera senegalensis leaves MK Parvez, MS Al-Dosari, AH Arbab, AJ Al-Rehaily, MAS Abdelwahid Saudi Pharmaceutical Journal 28 (5), 550-559, 2020 | 66 | 2020 |
| Natural or plant products for the treatment of neurological disorders: current knowledge MK Parvez Current drug metabolism 19 (5), 424-428, 2018 | 66 | 2018 |
| The hepatitis E virus ORF1 ‘X-domain’residues form a putative macrodomain protein/Appr-1 ″-pase catalytic-site, critical for viral RNA replication MK Parvez Gene 566 (1), 47-53, 2015 | 66 | 2015 |
| Quantitative analysis of rutin, quercetin, naringenin, and gallic acid by validated RP-and NP-HPTLC methods for quality control of anti-HBV active extract of Guiera senegalensis P Alam, MK Parvez, AH Arbab, MS Al-Dosari Pharmaceutical biology 55 (1), 1317-1323, 2017 | 61 | 2017 |
| The anti‐hepatitis B virus therapeutic potential of anthraquinones derived from Aloe vera MK Parvez, MS Al‐Dosari, P Alam, MT Rehman, MF Alajmi, AS Alqahtani Phytotherapy research 33 (11), 2960-2970, 2019 | 59 | 2019 |
| Analysis of antioxidative and antiviral biomarkers β-amyrin, β-sitosterol, lupeol, ursolic acid in Guiera senegalensis leaves extract by validated HPTLC methods MK Parvez, P Alam, AH Arbab, MS Al-Dosari, TA Alhowiriny, SI Alqasoumi Saudi pharmaceutical journal 26 (5), 685-693, 2018 | 57 | 2018 |
| Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-γ MK Parvez, D Sehgal, SK Sarin, SF Basir, S Jameel World Journal of Gastroenterology: WJG 12 (19), 3006, 2006 | 48 | 2006 |
| Design, synthesis and anticancer evaluation of novel quinazoline-sulfonamide hybrids MM Ghorab, MS Alsaid, MS Al-Dosari, MG El-Gazzar, MK Parvez Molecules 21 (2), 189, 2016 | 41 | 2016 |
| The in vitro and in vivo anti-hepatotoxic, anti-hepatitis B virus and hepatic CYP450 modulating potential of Cyperus rotundus MK Parvez, MS Al-Dosari, AH Arbab, S Niyazi Saudi Pharmaceutical Journal 27 (4), 558-564, 2019 | 38 | 2019 |
| Mutational analysis of hepatitis E virus ORF1" Y-domain": Effects on RNA replication and virion infectivity MK Parvez World journal of gastroenterology 23 (4), 590, 2017 | 38 | 2017 |
| Molecular modeling and analysis of hepatitis E virus (HEV) papain-like cysteine protease MK Parvez, AA Khan Virus research 179, 220-224, 2014 | 37 | 2014 |
| Chronic hepatitis E infection: risks and controls MK Parvez Intervirology 56 (4), 213-216, 2013 | 37 | 2013 |
